TheFly.com
Start Free Trial
<
Back to all Breaking News
ACRS
1/8/2018 07:01am
3
Street Research Stories
1
Calendar Events
chevron_right
Aclaris Therapeutics A-101 45% met primary, all secondary endpoints in 2 trials
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu
